Designing improved poly lactic-co-glycolic acid microspheres for a malarial vaccine: incorporation of alginate and polyinosinic–polycytidilic acid

References

• Adame-Gallegos JR, Shi J, McIntosh RS, Pleass RJ. The generation and evaluation of two panels of epitope-matched mouse IgG1, IgG2a, IgG2b and IgG3 antibodies specific for Plasmodium falciparum and Plasmodium yoelii Merozoite Surface Protein 1–19 (MSP119). Exp Parasitol, 2012;130:384–93
   PubMed Web of Science ®Google Scholar
• Aguilar JC, Rodriguez EG. Vaccine adjuvants revisited. Vaccine, 2007;25:3752–62
   PubMed Web of Science ®Google Scholar
• Anilbabu B, Srinivasarao G, Anbu J, Sivakumar L, Sukumaran N, Murugesan R, Sivakumar S, Shanmugarajan T, Ravichandran V. Immune augmentation of single contact hepatitis B vaccine by using PLGA microspheres as an adjuvant. Indian J Pharm Sci, 2008;70:487–90
   PubMed Web of Science ®Google Scholar
• Babu VR, Patel P, Mundargi RC, Rangaswamy V, Aminabhavi TM. Developments in polymeric devices for oral insulin delivery. Expert Opin Drug Deliv, 2008;5:403–15
   PubMed Web of Science ®Google Scholar
• Borges O, Silva M, de Sousa A, Borchard G, Junginger HE, Cordeiro-da-Silva A. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen. Int Immunopharmacol, 2008;8:1773–80
   PubMed Web of Science ®Google Scholar
• Carcaboso A, Hernández R, Igartua M, Rosas J, Patarroyo M, Pedraz J. Enhancing immunogenicity and reducing dose of microparticulated synthetic vaccines: Single intradermal administration. Pharm Res, 2004;21:121–6
   PubMed Web of Science ®Google Scholar
• Chaturvedi K, Ganguly K, Nadagouda MN, Aminabhavi TM. Polymeric hydrogels for oral insulin delivery. J Control Release, 2013;165:129–38
   PubMed Web of Science ®Google Scholar
• Chua BY, Al Kobaisi M, Zeng W, Mainwaring D, Jackson DC. Chitosan microparticles and nanoparticles as biocompatible delivery vehicles for peptide and protein-based immunocontraceptive Vaccines. Mol Pharm, 2012;9:81–90
   PubMed Web of Science ®Google Scholar
• Cui Z, Qiu F. Synthetic double-stranded RNA poly(I:C) as a potent peptide vaccine adjuvant: Therapeutic activity against human cervical cancer in a rodent model. Cancer Immunol Immunother, 2006;55:1267–79
   PubMed Web of Science ®Google Scholar
• De Gregorio E, D'Oro U, Wack A. Immunology of TLR-independent vaccine adjuvants. Curr Opin Immunol, 2009;21:339–45
   PubMed Web of Science ®Google Scholar
• Faisal SM, Yan W, McDonough SP, Chang Y. Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity. Vaccine, 2009;27:378–87
   PubMed Web of Science ®Google Scholar
• Garlapati S, Facci M, Polewicz M, Strom S, Babiuk LA, Mutwiri G, Hancock REW, Elliott MR, Gerdts V. Strategies to link innate and adaptive immunity when designing vaccine adjuvants. Vet Immunol Immunopathol, 2009;128:184–91
   PubMed Web of Science ®Google Scholar
• Giri TK, Choudhary C, Ajazuddin Alexander A, Badwaik H, Tripathi DK. Prospects of pharmaceuticals and biopharmaceuticals loaded microparticles prepared by double emulsion technique for controlled delivery. Saudi Pharm J, 2013;21:125–41
   PubMed Web of Science ®Google Scholar
• Giteau A, Venier-Julienne MC, Aubert-Pouëssel A, Benoit JP. How to achieve sustained and complete protein release from PLGA-based microparticles? Int J Pharm, 2008;350:14–26
   PubMed Web of Science ®Google Scholar
• Gombotz WR, Wee S. Protein release from alginate matrices. Adv Drug Deliv Rev, 1998;31:267–85
   PubMed Web of Science ®Google Scholar
• Hafner AM, Corthésy B, Textor M, Merkle HP. Tuning the immune response of dendritic cells to surface-assembled poly(I:C) on microspheres through synergistic interactions between phagocytic and TLR3 signaling. Vet Immunol Immunopathol, 2011;32:2651–61
   Google Scholar
• Hamdy S, Molavi O, Ma Z, Haddadi A, Alshamsan A, Gobti Z, Elhasi S, Samuel J, Lavasanifar A. Co-delivery of cancer-associated antigen and toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity. Vaccine, 2008;26:5046–57
   PubMed Web of Science ®Google Scholar
• Hunter RL, Kidd MR, Olsen MR, Patterson PS, Lal AA. Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants. J Immunol, 1995;154:1762–9
   PubMed Web of Science ®Google Scholar
• Jhunjhunwala S, Raimondi G, Thomson AW, Little SR. Delivery of rapamycin to dendritic cells using degradable microparticles. J Control Release, 2009;133:191–7
   PubMed Web of Science ®Google Scholar
• Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, Matsushita K, Hiiragi A, Dermody TS, Fujita T, Akira S. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med, 2008;205:1601–10
   PubMed Web of Science ®Google Scholar
• Kool M, Soullie T, van Nimwegen M, Willart MAM, Muskens F, Jung S, Hoogsteden HC, Hammad H, Lambrecht BN. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med, 2008;205:869–82
   PubMed Web of Science ®Google Scholar
• Kulkarni AR, Soppimath KS, Aminabhavi TM, Rudzinski WE. In-vitro release kinetics of cefadroxil-loaded sodium alginate interpenetrating network beads. Eur J Pharm Biopharm, 2001;51:127–33
   PubMed Web of Science ®Google Scholar
• Leclerc L, Rima W, Boudard D, Pourchez J, Forest V, Bin V, Mowat P, Perriat P, Tillement O, Grosseau P, et al. Size of submicrometric and nanometric particles affect cellular uptake and biological activity of macrophages in vitro. Inhal Toxicol, 2012;24:580–8
   PubMed Web of Science ®Google Scholar
• Li H, Nookala S, Re F. Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release. J Immunol, 2007;178:5271–6
   PubMed Web of Science ®Google Scholar
• Mata E, Carcaboso AM, Hernández RM, Igartua M, Corradin G, Pedraz JL. Adjuvant activity of polymer microparticles and montanide ISA 720 on immune responses to Plasmodium falciparum MSP2 long synthetic peptides in mice. Vaccine, 2007;25:877–85
   PubMed Web of Science ®Google Scholar
• Mata E, Igartua M, Hernández RM, Rosas JE, Patarroyo ME, Pedraz JL. Comparison of the adjuvanticity of two different delivery systems on the induction of humoral and cellular responses to synthetic peptides. Drug Deliv, 2010;17:490–9
   PubMed Web of Science ®Google Scholar
• Mata E, Igartua M, Patarroyo ME, Pedraz JL, Hernández RM. Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate. Eur J Pharm Sci, 2011;44:32–40
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Seya T. TLR3: Interferon induction by double-stranded RNA including poly(I:C). Adv Drug Deliv Rev, 2008;60:805–12
   PubMed Web of Science ®Google Scholar
• Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using Poly(d,l-lactide-co-glycolide) and its derivatives. J Control Release, 2008;125:193–209
   PubMed Web of Science ®Google Scholar
• Nazarian S, Gargari SLM, Rasooli I, Hasannia S, Pirooznia N. A PLGA-encapsulated chimeric protein protects against adherence and toxicity of enterotoxigenic Escherichia coli. Microbiol Res, 2014;162:205–12
   Google Scholar
• O'Hagan DT, MacKichan ML, Singh M. Recent developments in adjuvants for vaccines against infectious diseases. Biomol Eng, 2001;18:69–85
   PubMedGoogle Scholar
• Perrie Y, Mohammed AR, Kirby DJ, McNeil SE, Bramwell VW. Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens. Int J Pharm, 2008;364:272–80
   PubMed Web of Science ®Google Scholar
• Rice-Ficht AC, Arenas-Gamboa AM, Kahl-McDonagh MM, Ficht TA. Polymeric particles in vaccine delivery. Curr Opin Microbiol, 2010;13:106–12
   PubMed Web of Science ®Google Scholar
• Rosas JE, Hernández RM, Gascón AR, Igartua M, Guzman F, Patarroyo ME, Pedraz JL. Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66. Vaccine, 2001;19:4445–51
   PubMed Web of Science ®Google Scholar
• Salaun B, Greutert M, Romero P. Toll-like receptor 3 is necessary for dsRNA adjuvant effects. Vaccine, 2009;27:1841–7
   PubMed Web of Science ®Google Scholar
• Salem ML, El-Naggar S, Kadima A, Gillanders WE, Cole DJ. The adjuvant effects of the toll-like receptor 3 ligand polyinosinic–cytidylic acid poly (I:C) on antigen-specific CD8+ T cell responses are partially dependent on NK cells with the induction of a beneficial cytokine milieu. Vaccine, 2006;24:5119–32
   PubMed Web of Science ®Google Scholar
• Salvador A, Hernandez RM, Pedraz JL, Igartua M. Plasmodium falciparum malaria vaccines: Current status, pitfalls and future directions. Expert Rev Vacc, 2012a;11:1071–86
   PubMed Web of Science ®Google Scholar
• Salvador A, Igartua M, Hernandez RM, Pedraz JL. Combination of immune stimulating adjuvants with poly(lactide-co-glycolide) microspheres enhances the immune response of vaccines. Vaccine, 2012b;30:589–96
   PubMed Web of Science ®Google Scholar
• Salvador A, Igartua M, Pedraz JL, Hernández RM. 2012c. Dendritic cells interactions with the immune system – Implications for vaccine development. In: Gowder S, ed. Cell interaction. USA Intech, pp. 69–92
   Google Scholar
• Sauerwein RW. Clinical malaria vaccine development. Immunol Lett, 2009;122:115–17
   PubMed Web of Science ®Google Scholar
• Sharp FA, Ruane D, Claass B, Creagh E, Harris J, Malyala P, Singh M, O'Hagan DT, Pétrilli V, Tschopp J, et al. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc Natl Acad Sci USA, 2009;106:870–5
   PubMed Web of Science ®Google Scholar
• Soppimath KS, Aminabhavi TM. Ethyl acetate as a dispersing solvent in the production of poly(dl-lactide-co-glycolide) microspheres: Effect of process parameters and polymer type. J Microencapsul, 2002;19:281–92
   PubMed Web of Science ®Google Scholar
• Verdijk RM, Mutis T, Esendam B, Kamp J, Melief CJM, Brand A, Goulmy E. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. J Immunol, 1999;163:57–61
   PubMed Web of Science ®Google Scholar
• Walter E, Dreher D, Kok M, Thiele L, Kiama SG, Gehr P, Merkle HP. Hydrophilic poly(lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells. J Control Release, 2001;76:149–68
   PubMed Web of Science ®Google Scholar
• Wischke C, Zimmermann J, Wessinger B, Schendler A, Borchert H, Peters JH, Nesselhut T, Lorenzen DR. Poly(I:C) coated PLGA microparticles induce dendritic cell maturation. Int J Pharm, 2009;365:61–8
   PubMed Web of Science ®Google Scholar
• Zheng C, Gao J, Zhang Y, Liang W. A protein delivery system: biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres. Biochem Biophys Res Commun, 2004;323:1321–7
   PubMed Web of Science ®Google Scholar